As co-founder and President of Carelon Research (formerly HealthCore), Mark Cziraky, PharmD, CLS, has been extensively involved with clinical and health economics, and outcomes research for more than 25 years. Prior to becoming President, Mark was most recently responsible for leading Scientific Affairs and global scientific and business development at Carelon Research. He has held additional leadership roles at the company, including running individual research units and leading business development teams. Mark remains dedicated to the Carelon Research goal to provide information to enable healthcare decision makers to assess the real-world value of pharmaceutical products and medical devices. He serves as a key architect in creating open-source research collaborations within the healthcare industry that allow health plans to be involved in research design and execution with various collaborating organizations.
Mark’s experience spans leadership roles in clinical pharmacy practice with a focus on cardiovascular risk management, academics, clinical trial management, health policy, and retrospective and prospective observational research design and conduct. Mark is a nationally recognized presenter on both cardiovascular and health economics and outcomes research related topics and has published numerous original research, review papers, and book chapters in these areas.
Prior to starting Carelon Research (formerly HealthCore), Mark held a full-time faculty position at the Philadelphia College of Pharmacy and Science, now part of Saint Joseph's University in Philadelphia and implemented and managed a physician-referred patient care program focused on dyslipidemia management for Blue Cross Blue Shield of Delaware.
Follow us on LinkedIn to learn how our leaders are solving today’s most complex health challenges.